Some Biologic Treatments for Psoriasis May Be Safer for Patients
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
A review highlights nutritional deficiencies associated with GLP-1 medications and bariatric surgery that may affect wound healing and recovery.